{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:21:41Z","timestamp":1786119701311,"version":"build-2736575974"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1097\/coc.0b013e318210f812","type":"journal-article","created":{"date-parts":[[2011,3,5]],"date-time":"2011-03-05T08:15:00Z","timestamp":1299312900000},"page":"228-236","source":"Crossref","is-referenced-by-count":15,"title":["Adjuvant Chemotherapy and Risk of Gastrointestinal, Hematologic, and Cardiac Toxicities in Elderly Patients With Stage III Colon Cancer"],"prefix":"10.1097","volume":"35","author":[{"given":"Chung-Yuan","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyaw","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George P.","family":"Delclos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianglin L.","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210128","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1200\/JCO.1989.7.10.1447","article-title":"Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.","volume":"7","author":"Laurie","year":"1989","journal-title":"J Clin Oncol"},{"key":"R2-5-20210128","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1056\/NEJM199002083220602","article-title":"Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.","volume":"322","author":"Moertel","year":"1990","journal-title":"N Engl J Med"},{"key":"R3-5-20210128","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1200\/JCO.1993.11.10.1879","article-title":"The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03.","volume":"11","author":"Wolmark","year":"1993","journal-title":"J Clin Oncol"},{"key":"R4-5-20210128","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1046\/j.1524-4733.2002.51083.x","article-title":"The incidence and cost of hospitalization for 5-FU toxicity among Medicare beneficiaries with metastatic colorectal cancer.","volume":"5","author":"Delea","year":"2002","journal-title":"Value Health"},{"key":"R5-5-20210128","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJM199404213301608","article-title":"Chemotherapy for colorectal cancer.","volume":"330","author":"Moertel","year":"1994","journal-title":"N Engl J Med"},{"key":"R6-5-20210128","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/1097-0142(19950101)75:1<11::AID-CNCR2820750104>3.0.CO;2-N","article-title":"Age and sex are independent predictors of 5-fluorouracil toxicity: analysis of a large scale phase III trial.","volume":"75","author":"Stein","year":"1995","journal-title":"Cancer"},{"key":"R8-5-20210128","doi-asserted-by":"crossref","first-page":"8671","DOI":"10.1200\/JCO.2004.00.5686","article-title":"Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.","volume":"23","author":"Haller","year":"2005","journal-title":"J Clin Oncol"},{"key":"R9-5-20210128","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1200\/JCO.1998.16.1.295","article-title":"Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer.","volume":"16","author":"OConnell","year":"1998","journal-title":"J Clin Oncol"},{"key":"R10-5-20210128","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1200\/JCO.1999.17.11.3553","article-title":"Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes B and C carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project C-04.","volume":"17","author":"Wolmark","year":"1999","journal-title":"J Clin Oncol"},{"key":"R12-5-20210128","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/15563650701438763","article-title":"A case of 5-fluorouracil-induced peripheral neuropathy.","volume":"46","author":"Werbrouck","year":"2008","journal-title":"Clin Toxicol (Phila)"},{"key":"R13-5-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/187152506775268785","article-title":"Cardiotoxicity of 5-fluorouracil.","volume":"4","author":"Alter","year":"2006","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"R14-5-20210128","first-page":"205","article-title":"5-fluorouracil cardiotoxicity is a rare, dose and schedule-dependent adverse event: a prospective study.","volume":"10","author":"Tsavaris","year":"2005","journal-title":"J BOUN"},{"key":"R15-5-20210128","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1055\/s-2008-1065055","article-title":"Cardiac side effects of 5-fluorouracil.","volume":"115","author":"May","year":"1990","journal-title":"Dtsch Med Wochenschr"},{"key":"R17-5-20210128","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1345\/aph.1E070","article-title":"Fluorouracil-induced neurotoxicity presenting with generalized tonic-clonic seizure.","volume":"38","author":"Elkiran","year":"2004","journal-title":"Ann Pharmacother"},{"key":"R18-5-20210128","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/107327480401100107","article-title":"5-fluorouracil-induced coronary vasospasm.","volume":"11","author":"Shoemaker","year":"2004","journal-title":"Cancer Control"},{"key":"R19-5-20210128","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2459\/JCM.0b013e32832e934b","article-title":"5-Fluorouracil-induced coronary vasospasm.","volume":"11","author":"Bathina","year":"2010","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"R20-5-20210128","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1200\/JCO.1992.10.11.1795","article-title":"Cardiotoxicity of high-dose continuous infusion fluorouracil: a prospective clinical study.","volume":"10","author":"de Forni","year":"1992","journal-title":"J Clin Oncol"},{"key":"R21-5-20210128","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/1097-0142(19931001)72:7<2242::AID-CNCR2820720730>3.0.CO;2-E","article-title":"Cardiotoxicity of 5-fluorouracil in combination with folinic acid in patients with gastrointestinal cancer.","volume":"72","author":"Schober","year":"1993","journal-title":"Cancer"},{"key":"R22-5-20210128","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ctrv.2003.07.003","article-title":"Cardiotoxicity of cytotoxic drugs.","volume":"30","author":"Schimmel","year":"2004","journal-title":"Cancer Treat Rev"},{"key":"R23-5-20210128","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/1097-0142(19930115)71:2<493::AID-CNCR2820710235>3.0.CO;2-C","article-title":"The syndrome of 5-fluorouracil cardiotoxicity: an elusive cardiopathy.","volume":"71","author":"Robben","year":"1993","journal-title":"Cancer"},{"key":"R24-5-20210128","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3747\/co.v17i1.437","article-title":"Capecitabine-induced cardiotoxicity: case report and review of the literature.","volume":"17","author":"Ang","year":"2010","journal-title":"Curr Oncol"},{"key":"R25-5-20210128","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2261-1-3","article-title":"5-fluorouracil-induced cardiotoxicity mimicking myocardial infarction: a case report.","volume":"1","author":"McGlinchey","year":"2001","journal-title":"BMC Cardiovasc Disord"},{"key":"R26-5-20210128","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1200\/JCO.2001.19.5.1455","article-title":"Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare claims data.","volume":"19","author":"Du","year":"2001","journal-title":"J Clin Oncol"},{"key":"R27-5-20210128","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00005650-200004000-00008","article-title":"Agreement of Medicare claims and tumor registry data for assessment of cancer-related treatment.","volume":"38","author":"Cooper","year":"2000","journal-title":"Med Care"},{"key":"R28-5-20210128","first-page":"IV","article-title":"Utility of the SEER-Medicare data to identify chemotherapy use.","volume":"40","author":"Warren","year":"2002","journal-title":"Med Care"},{"key":"R30-5-20210128","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/00005650-199308000-00006","article-title":"Potential for cancer related health services research using a linked Medicare-tumor registry database.","volume":"31","author":"Potosky","year":"1993","journal-title":"Med Care"},{"key":"R31-5-20210128","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/cncr.22826","article-title":"Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer.","volume":"110","author":"Du","year":"2007","journal-title":"Cancer"},{"key":"R32-5-20210128","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"R35-5-20210128","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1200\/JCO.2002.20.6.1491","article-title":"Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer.","volume":"20","author":"Sloan","year":"2002","journal-title":"J Clin Oncol"},{"key":"R36-5-20210128","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/oxfordjournals.eurheartj.a059919","article-title":"Coronary artery spasm induced by 5-fluorouracil.","volume":"12","author":"Luwaert","year":"1991","journal-title":"Eur Heart J"},{"key":"R37-5-20210128","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/j.1552-4604.1993.tb01943.x","article-title":"Clinical cardiotoxicity of 5-fluorouracil.","volume":"33","author":"Keefe","year":"1993","journal-title":"J Clin Pharmacol"},{"key":"R38-5-20210128","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1377\/hlthaff.24.6.1571","article-title":"Reporting clinical trial results to inform providers, payers, and consumers.","volume":"24","author":"Hayward","year":"2005","journal-title":"Health Aff (Millwood)"},{"key":"R39-5-20210128","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.1002\/cncr.24621","article-title":"Cardiac toxicity associated with anthracycline-containing chemotherapy in older women with breast cancer.","volume":"115","author":"Du","year":"2009","journal-title":"Cancer"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000421-201206000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:47:24Z","timestamp":1786042044000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000421-201206000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0b013e318210f812","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}